Results 181 to 190 of about 4,201,815 (397)

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Exploring the potential of the metaverse medical paradigm in drug addiction treatment: a preliminary discussion and future prospects. [PDF]

Gen Psychiatr, 2023
Yang L, Zhang L, Yang W, Tang F, Du Y, Liu J.   +5 more
europepmc   +1 more source

Multiple-Drug Addiction in New York City in a Selected Population Group: A Statistical Review [PDF]

, 1966
Hans Abeles, Ralph Plew, Irving Laudeutscher, Harvey M. Rosenthal   +3 more
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Substance Misuse Education for Physicians: Why Older People are Important. [PDF]

, 2016
This perspective article focuses on the need for training and education for undergraduate medical students on substance-related disorders, and describes initiatives undertaken in the United Kingdom (UK), Netherlands, United States (US), and Norway to ...
Broers, B, Crome, I, De Jong, CAJ, Dom, G, El-Guebaly, N, Goodair, C, Jokubonis, D, Luycks, L, Schellekens, A, Schoof, T, Subata, E, Welle-Strand, GK, Wolters, M   +12 more
core   +1 more source

Recurrent Psychotic Episodes Induced by Synthetic Cathinones in a Monozygotic Twin with Drug Addiction: A Case Report. [PDF]

Consort Psychiatr, 2023
Severtsev VV, Budanova AA.
europepmc   +1 more source

Drug Addiction [Abridged] [PDF]

, 1968
Thomas Bewley
openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Addiction, compulsion, and weakness of the will: A dual process perspective [PDF]

, 2016
How should addictive behavior be explained? In terms of neurobiological illness and compulsion, or as a choice made freely, even rationally, in the face of harmful social or psychological circumstances?
Henden, Edmund
core  

Immunotherapies for the Treatment of Drug Addiction. [PDF]

Vaccines (Basel), 2022
Hossain MK, Davidson M, Kypreos E, Feehan J, Muir JA, Nurgali K, Apostolopoulos V.   +6 more
europepmc   +1 more source